Absence of a NS3 specific T cell response in HCV infection is associated with high viral load but not with extensive genetic heterogeneity

被引：0
|
作者：
Nattermann, J
Peters, T
Diepolder, HM
Pape, GR
Rasenack, J
机构：
[1] Univ Hosp, Dept Med 2, D-79106 Freiburg, Germany
[2] Univ Munich, Klinikum Grosshadern, Dept Med 2, D-81377 Munich, Germany
[3] Univ Munich, Inst Immunol, D-81377 Munich, Germany
来源：
HEPATOLOGY | 1998年 / 28卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1600
引用
收藏
页码：562A / 562A
页数：1
相关论文
共 50 条
  • [31] The Combination of Grazoprevir, a Hepatitis C Virus (HCV) NS3/4A Protease Inhibitor, and Elbasvir, an HCV NS5A Inhibitor, Demonstrates a High Genetic Barrier to Resistance in HCV Genotype 1a Replicons
    Lahser, Frederick C.
    Bystol, Karin
    Curry, Stephanie
    McMonagle, Patricia
    Xia, Ellen
    Ingravallo, Paul
    Chase, Robert
    Liu, Rong
    Black, Todd
    Hazuda, Daria
    Howe, Anita Y. M.
    Asante-Appiah, Ernest
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (05) : 2954 - 2964
  • [32] Sustained Specific and Cross-Reactive T Cell Responses to Zika and Dengue Virus NS3 in West Africa
    Herrera, Bobby Brooke
    Tsai, Wen-Yang
    Chang, Charlotte A.
    Hamel, Donald J.
    Wang, Wei-Kung
    Lu, Yichen
    Mboup, Souleymane
    Kanki, Phyllis J.
    JOURNAL OF VIROLOGY, 2018, 92 (07)
  • [33] Does prolonged therapy in HCV-genotype 3 patients with high viral load improve sustained viral response rates?
    Mauss, Stefan
    Hueppe, Dietrich
    Zehnter, Elmar
    Manns, Michael P.
    Teuber, Gerlinde
    Dahhan, Tarek
    Meyer, Ulrike
    Moeller, Bernd
    Dikopoulos, Nektarios
    Witthoeft, Thomas
    Brack, Jochen
    Stern, Marek
    Kaiser, Stephan
    Prinzing, Renate
    HEPATOLOGY, 2007, 46 (04) : 362A - 363A
  • [34] FINDINGS FROM CLINICAL VIROLOGY STUDIES ON SOVAPREVIR, A PHASE 2 HCV NS3 PROTEASE INHIBITOR, INDICATE A HIGH PHARMACOLOGICAL BARRIER TO VIRAL RESISTANCE
    Fabrycki, J.
    Zhao, Y.
    Patel, D.
    Yang, G.
    Podos, S.
    Yang, W.
    Robison, H.
    Robarge, L.
    Kocinsky, H.
    Olek, E.
    Deshpande, M.
    Huang, M.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S488 - S488
  • [35] Assessment of viral load in patients with chronic HCV infection: Comparison between 3 quantitative assays and prediction of response to therapy
    Pradat, P
    Chossegros, P
    Bailly, F
    Chemello, L
    Sauleda, S
    Saracco, G
    Thursz, M
    Tillmann, H
    GASTROENTEROLOGY, 1999, 116 (04) : A1263 - A1263
  • [36] Aged Environment Impairs Specific CD8 T Cell Response to Viral Infection
    Jiang, Jiu
    Bennett, Andrew J.
    Murasko, Donna M.
    FASEB JOURNAL, 2008, 22
  • [37] Determinants in the envelope E protein and viral RNA helicase NS3 that influence the induction of apoptosis in response to infection with dengue type 1 virus
    dos Santos, CND
    Frenkiel, MP
    Courageot, MP
    Rocha, CFS
    Vazeille-Falcoz, MC
    Wien, MW
    Rey, FA
    Deubel, V
    Desprès, P
    VIROLOGY, 2000, 274 (02) : 292 - 308
  • [38] Dendritic cells expressing hepatitis C virus (HCV) derived antigens NS3 or Core: phenotype, antigen presentation and T cell stimulation
    Agrawal, B.
    Li, W.
    Tyrrell, D.
    Krishnadas, D.
    Li, J.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S170 - S170
  • [39] Establishment and characterization of NS3 protein-specific T-cell clones from a patient with chronic hepatitis C
    Chiang, BL
    Yang, PM
    Hwang, LH
    Wang, JM
    Kao, SF
    Pan, CH
    Chi, WK
    Chen, PJ
    Chen, DS
    JOURNAL OF BIOMEDICAL SCIENCE, 1998, 5 (04) : 290 - 296
  • [40] CD4 and CD8 T cell response to the entire HCV core and NS3-NS5 antigens in HCV persistence and clearance.
    Sugimoto, K
    Ikeda, F
    Stadanlick, J
    Valiga, M
    Chang, KM
    HEPATOLOGY, 2002, 36 (04) : 274A - 274A
12345